Methyl 2-(6-oxo-3-phenylpyridazin-1(6H)-yl)acetate

Catalog No.: 
ACINKZ116
CAS No.: 
853319-62-7
Molecular Formula: 
C13H12N2O3
Molecular Weight: 
244.25
Methyl 2-(6-oxo-3-phenylpyridazin-1(6H)-yl)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$91.00InquiryInquiry
250mg95%$174.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 2-(6-oxo-3-phenylpyridazin-1(6H)-yl)acetate
IUPAC Namemethyl 2-(6-oxo-3-phenylpyridazin-1(6H)-yl)acetate
MDL No.MFCD07799323
Molecular FormulaC13H12N2O3
Molecular Weight244.25
SMILESO=C(OC)CN1C(C=CC(C2=CC=CC=C2)=N1)=O
InChI KeyJLFXLYDKBDJTQE-UHFFFAOYSA-N
SynonymMethyl (6-oxo-3-phenylpyridazin-1(6H)-yl)acetate;Methyl 2-(6-oxo-3-phenyl-1,6-dihydropyridazin-1-yl)acetate;1(6H)-Pyridazineacetic acid, 6-oxo-3-phenyl-, methyl ester;METHYL (6-OXO-3-PHENYL-1(6H)-PYRIDAZINYL)ACETATE
CAS No.853319-62-7

Synthetic Route by SureRoute

1. ACINKZ116 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTUEB193 route compound structure diagram
    ACTUEB1932166-31-6In Stock
  4. Then
  5. ACINKZ116 route product structure diagram
    ACINKZ116853319-62-7
Inquiry

2. ACINKZ116 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQROT208 route compound structure diagram
    ACQROT20898-80-6In Stock
  4. Then
  5. ACINKZ116 route product structure diagram
    ACINKZ116853319-62-7
Inquiry

3. ACINKZ116 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTUEB193 route compound structure diagram
    ACTUEB1932166-31-6In Stock
  4. Then
  5. ACINKZ116 route product structure diagram
    ACINKZ116853319-62-7
Inquiry

Comments (0)